Showing results (101-110 of 119) with videos related to
Sort By:
Pageof 12
Pharmaceutics|November 11, 2022
Sequential Delivery of Novel Triple Drug Combination via Crosslinked Alginate/Lactoferrin Nanohybrids for Enhanced Breast Cancer TreatmentMai Salah, Marwa A Sallam, Mona A Abdelmoneem, et al.Colloids and Surfaces. B, Biointerfaces|July 8, 2022
Green self-assembled lactoferrin carboxymethyl cellulose nanogels for synergistic chemo/herbal breast cancer therapyMai A Atallah, Marwa A Sallam, Mona A Abdelmoneem, et al.Scientific Reports|May 8, 2023
Optimized spirooxindole-pyrazole hybrids targeting the p53-MDM2 interplay induce apoptosis and synergize with doxorubicin in A549 cellsMohammad Shahidul Islam, Abdullah Mohammed Al-Majid, Essam Nageh Sholkamy, et al.Bioorganic Chemistry|November 18, 2021
Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activatorsGehad Lotfy, Yasmine M Abdel Aziz, Mohamed M Said, et al.Colloids and Surfaces. B, Biointerfaces|March 19, 2021
A novel 'smart' PNIPAM-based copolymer for breast cancer targeted therapy: Synthesis, and characterization of dual pH/temperature-responsive lactoferrin-targeted PNIPAM-co-AAOsama R M Metawea, Mona A Abdelmoneem, Nesreen Saied Haiba, et al.ACS Medicinal Chemistry Letters|May 14, 2025
Synthesis of Marine-Inspired Multifaceted DNA Damaging Spirooxindoles Combating NSCLC and Associated Bacterial InfectionMohammad Shahidul Islam, Assem Barakat, Abdul Majeed Abdullah Alayyaf, et al.International Journal of Molecular Sciences|October 13, 2021
Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological EvaluationFawzia Faleh Albelwi, Mohamed Teleb, Marwa M Abu-Serie, et al.ACS Omega|May 20, 2024
Triggering Breast Cancer Apoptosis via Cyclin-Dependent Kinase Inhibition and DNA Damage by Novel Pyrimidinone and 1,2,4-Triazolo[4,3-a]pyrimidinone DerivativesMohamed N Abd Al Moaty, Yeldez El Kilany, Laila F Awad, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|November 23, 2023
New spiro-indeno[1,2-b]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insightsAssem Barakat, Saeed Alshahrani, Abdullah Mohammed Al-Majid, et al.Materials Science & Engineering. C, Materials for Biological Applications|December 1, 2020
Lactoferrin-dual drug nanoconjugate: Synergistic anti-tumor efficacy of docetaxel and the NF-κB inhibitor celastrolMona A Abdelmoneem, Mahmoud M Abd Elwakil, Sherine N Khattab, et al.Pageof 12